Updated 2 years ago
An emerging industry aims to help people pick the best drug for their ailments—and the right dose.
“Entheon’s psychedelic test looks at five factors:
1. A liver enzyme for ketamine metabolism,
2. Serotonin receptor variations to gauge “psychedelics sensitivity,” and
3. – 5. Three other factors to weigh “mental health risk” by analyzing genes believed to influence responses to THC and CBD—including a test for the AKT1 gene, which the National Institute on Drug Abuse has identified as potentially linked to a higher risk of psychosis in people who use marijuana … parsing 57 genetic traits that could influence a customer’s response to marijuana, so they can select the best strain and correct dose.”
